JS-401

N/A

Report date: 2025/04/01 15:10:14
NME

Base Information

Drug NameJS-401
Drug Alias NameJS-401RP-912
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 inhibitorsRNA interference
TargetsAngiopoietin like 3
Therapy Area/IndicationsHyperlipidemiasMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRisen (Suzhou) Pharma Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWuxi Runmin Pharmaceutical Technology Co LtdRisen (Suzhou) Pharma Tech Co LtdShanghai Junshi Biosciences Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A